CHAD and sarcopenia: Experimental validation confirmed significant upregulation of USP54, CHAD, and ZDBF2 in aging muscles, and functional analysis revealed enrichment of signaling pathways related to bone development, immune response, and apoptosis, consistent with known mechanisms of sarcopenia [177].